FENNEC PHARMACEUTICALS INC. (FENC)

12.27 +4.25% (+0.50)

Over 1M: +28.2%

2026-08-28
Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

10 11 12 13
31 Jul 5 Aug 10 Aug 13 Aug 18 Aug 21 Aug 26 Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Operating Cash Flow: -3M Q3 '21 — Net Income: -4.2M Q4 '21 — Operating Cash Flow: -3.2M Q4 '21 — Net Income: -4.4M Q1 '22 — Operating Cash Flow: -2.9M Q1 '22 — Net Income: -3.7M Q2 '22 — Operating Cash Flow: -3.4M Q2 '22 — Net Income: -5.1M Q3 '22 — Operating Cash Flow: -5M Q3 '22 — Net Income: -8.1M Q4 '22 — Operating Cash Flow: -6.8M Q4 '22 — Net Income: -6.9M Q1 '23 — Revenue: 1.7M Q1 '23 — Operating Cash Flow: -5.6M Q1 '23 — Net Income: -6.1M Q2 '23 — Revenue: 3.3M Q2 '23 — Operating Cash Flow: -3.9M Q2 '23 — Net Income: -5.4M Q3 '23 — Revenue: 6.5M Q3 '23 — Operating Cash Flow: -2.8M Q3 '23 — Net Income: -1.9M Q4 '23 — Revenue: 10M Q4 '23 — Operating Cash Flow: -4.9M Q4 '23 — Net Income: -28.5M Q1 '24 — Revenue: 25.4M Q1 '24 — Operating Cash Flow: 39M Q1 '24 — Net Income: 12.8M Q2 '24 — Revenue: 7.3M Q2 '24 — Operating Cash Flow: -8.4M Q2 '24 — Net Income: -5.6M Q3 '24 — Revenue: 7M Q3 '24 — Operating Cash Flow: -2.2M Q3 '24 — Net Income: -5.7M Q4 '24 — Revenue: 7.9M Q4 '24 — Operating Cash Flow: -1.5M Q4 '24 — Net Income: -2M Q1 '25 — Revenue: 8.8M Q1 '25 — Operating Cash Flow: -4.3M Q1 '25 — Net Income: -1.2M Q2 '25 — Revenue: 9.7M Q2 '25 — Operating Cash Flow: -3.7M Q2 '25 — Net Income: -3.2M Q3 '25 — Revenue: 12.5M Q3 '25 — Operating Cash Flow: 1.5M Q3 '25 — Net Income: -638K Q4 '25 — Revenue: 13.8M Q4 '25 — Operating Cash Flow: -6M Q4 '25 — Net Income: -4.8M Q1 '26 — Revenue: 15.1M Q1 '26 — Operating Cash Flow: 2.4M Q1 '26 — Net Income: 201K Q2 '26 — Revenue: 17.9M Q2 '26 — Operating Cash Flow: 50K Q2 '26 — Net Income: 2M -15M 0 15M 30M 45M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

1.8
SBC / sales 12.7%
OE margin -16.1%
Oper. margin -1.9%
ROIC -74.5%
Accruals -1.6%
FCF margin -3.4%
OCF margin -3.4%
ROA -4.3%
ROCE -1.8%
ROE -7.7%
Capex / sales —
EBITDA margin —
Gross margin —
OCF / EBIT —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

2.8
RPO / sales 0.054×
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.5
ND/EBITDA —
Cash runway 20.2 yr
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 5.8×
F-score 0.0 pts
Cash / Debt —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

9.7
Sales CAGR 4Y +204.7%
Sales/sh Y/Y +69.8%
Gross profit Y/Y +1279.8%
Sales Q/Q +85.2%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.